Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
- Publication date
- 5 December 2017
- Publisher
- 'Springer Science and Business Media LLC'